Jim O’Neill, a prominent figure in public health and acting director of the Centers for Disease Control and Prevention (CDC), recently sat down for an exclusive interview with MIT Technology Review to discuss evolving vaccine recommendations, emerging dietary guidance, and his personal commitment to longevity research. While acknowledging the recent controversial overhaul of the childhood vaccine schedule, O’Neill emphasized that such guidelines are "still subject to new data coming in, new ways of thinking about things," and that the CDC, FDA, and NIH are actively initiating new studies into immunization safety. He stated that the decision to revise the vaccine schedule was prompted by President Trump’s request to align US recommendations with those of other developed nations, aiming to focus on "consensus vaccines" deemed most important for all children, without limiting access. However, O’Neill also acknowledged parental concerns about the high number of recommended doses and expressed a belief that the updated schedule addresses these concerns. He confirmed that the CDC still recommends a core set of vaccines with international consensus, including those for diphtheria, tetanus, pertussis, Hib, pneumococcal conjugate, polio, measles, mumps, rubella, HPV, and varicella. He assured that the Advisory Committee on Immunization Practices will continue to review evidence and make updated recommendations based on rigorous science and transparency.

Beyond vaccine policy, O’Neill revealed his deep personal interest in longevity, a field he believes can be significantly advanced through federal funding and research. He articulated his ultimate goal of bringing "the damage of aging… under medical control," viewing it as an extension of the "Make America Healthy Again" initiative. His enthusiasm for longevity was sparked by tech entrepreneur Peter Thiel, who encouraged him to explore the potential for reversing age-related damage. O’Neill even identified himself as a "Vitalist," agreeing with the movement’s core tenets that "death is humanity’s core problem" and that "obviating aging is scientifically plausible." He sees a strong alignment between this philosophy and the broader mission of the Department of Health and Human Services (HHS), stating, "reversing aging damage is all about making people healthy again." He highlighted the agency’s refocus on addressing and reversing chronic diseases, which he believes are intrinsically linked to aging.

O’Neill expressed optimism about the future of longevity research, particularly through the Advanced Research Projects Agency for Health (ARPA-H). He played a role in recruiting ARPA-H’s new director, Alicia Jackson, whose expertise in women’s health and longevity is expected to steer the agency’s focus. O’Neill also highlighted the work of Andrew Brack, who is investigating biological markers of aging, and Jean Hébert, who is exploring methods for replacing aging brain tissue. O’Neill expressed particular excitement about the prospect of growing new organs for transplantation from a patient’s own cells, an initiative that ARPA-H is dedicating significant funding to.

The US Deputy Health Secretary also indicated that longevity lobbyists have a receptive audience within HHS. He regularly communicates with the Alliance for Longevity Initiatives (A4LI), an organization that advocates for increased support for aging research and streamlined access to experimental therapies. While O’Neill suggested that creating a new NIH institute dedicated solely to aging might be ambitious, he expressed a desire for all NIH institutes to consider chronic diseases as pathologies of aging. He also alluded to potential increases in federal funding for such research, without providing specific details. O’Neill’s past support for concepts like "freedom cities" and seasteading, which aim to create environments that encourage innovation and potentially reduce governmental regulation, suggests an openness to exploring radical approaches to healthcare and societal development, particularly those that prioritize innovation.

In the realm of nutrition, O’Neill indicated that HHS is investing in more research and randomized controlled trials, acknowledging that nutrition remains a "scientifically not solved problem." He expressed particular interest in identifying "the healthiest fats" and hinted at future updates from HHS on this front. He personally adopts a straightforward approach to longevity, which includes minimizing sugar and ultraprocessed foods, prioritizing exercise and sleep, and supplementing with vitamin D. He also aligns with the new dietary guidance from HHS and the Department of Agriculture, which emphasizes a diet rich in protein and saturated fat, despite criticisms from some nutrition scientists.

The interview also noted that Jim O’Neill was reportedly slated to leave his roles within the Department of Health and Human Services following the publication of this story, according to a Politico report.